Syndax Pharmaceuticals, Inc. (SNDX)
SNDX chart
Everything the smart money is doing in SNDX
This is the SNDX details page members see in the GTA Terminal. Previews below are blurred samples; start a free trial to see the live data.
Option Flows for SNDX
Every unusual options bet in SNDX: size, strikes, expirations and which side the money is on.
Start 14-day free trialAlready a member? Open in the Terminal →Insiders & Congress for SNDX
2 insider filings on record for SNDX. See who bought and sold, how much, and when.
Start 14-day free trialAlready a member? Open in the Terminal →Institutions for SNDX
Which hedge funds and institutions are buying and selling SNDX.
Start 14-day free trialAlready a member? Open in the Terminal →Short interest for SNDX
Short interest data for SNDX through 2026-09-30: percent of shares short, days to cover and the squeeze score.
Start 14-day free trialAlready a member? Open in the Terminal →Financials & earnings for SNDX
Eight quarters of revenue, margins and EPS for SNDX, every earnings beat and miss, and conference-call notes.
Start 14-day free trialAlready a member? Open in the Terminal →GTA AI for SNDX
Ask GTA AI for a trade idea on SNDX: bias, entry, stop and target, built from all of the data above.
Start 14-day free trialAlready a member? Open in the Terminal →Sample previews with placeholder values. Then $99/month. Cancel anytime.
Technical summary daily
| Moving average | Simple | Exponential | Signal |
|---|---|---|---|
| MA5 | 16.24 | 15.91 | Sell |
| MA10 | 17.10 | 16.68 | Sell |
| MA20 | 17.49 | 17.42 | Sell |
| MA50 | 18.84 | 18.56 | Sell |
| MA100 | 19.62 | 19.36 | Sell |
| MA200 | 20.72 | 19.67 | Sell |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 24.17 | Oversold |
| MACD(12,26) | -0.85 | Sell |
| Stochastic(14) | 4.60 | Oversold |
| ROC(12) | -24.45 | Sell |
Classic pivot points from the last full session. Technical signals are mechanical readings, not recommendations.
Syndax Pharmaceuticals, Inc. news
Top Midday DeclinersMT Newswires · 1 hr agoSyndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans.Barrons.com · 4 hr agoSyndax Pharmaceuticals Selloff After IPF Trial Failure Appears 'Overdone,' BofA Securities SaysMT Newswires · 4 hr agoBofA Securities Adjusts Syndax Pharmaceuticals PT to $23 From $26, Maintains Buy RatingMT Newswires · 7 hr agoSyndax Pharmaceuticals (SNDX) Is Down 7.2% After Axatilimab IPF Trial Misses Endpoint Has The Bull Case Changed?Simply Wall St. · 15 hr agoSNDX Stock Slumps 16% After-Hours — What’s Driving The Selloff?Stocktwits · 21 hr agoSyndax Pharmaceuticals' Axatilimab Trial in Pulmonary Fibrosis Misses Primary EndpointMT Newswires · 22 hr agoSyndax Pharmaceuticals stock tumbles on failed IPF trialInvesting.com · 22 hr agoHow do you see Syndax Pharmaceuticals, Inc. today?
Results show once a few readers have voted today.
Historical data daily, last 20 sessions
| Date | Price | Open | High | Low | Vol. | Change % |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | 13.75 | 14.61 | 14.72 | 13.50 | 5.32M | -16.92% |
| Oct 12, 2026 | 16.55 | 16.88 | 16.95 | 16.37 | 2.03M | -2.59% |
| Oct 09, 2026 | 16.99 | 16.91 | 17.42 | 16.78 | 1.46M | +0.53% |
| Oct 08, 2026 | 16.90 | 16.90 | 17.28 | 16.39 | 2.14M | -0.76% |
| Oct 07, 2026 | 17.03 | 17.17 | 17.69 | 17.03 | 1.59M | -1.96% |
| Oct 06, 2026 | 17.37 | 17.99 | 18.19 | 16.85 | 1.14M | -2.58% |
| Oct 05, 2026 | 17.83 | 17.58 | 17.98 | 17.57 | 1.46M | +1.31% |
| Oct 02, 2026 | 17.60 | 18.46 | 18.46 | 17.52 | 2.56M | -3.40% |
| Oct 01, 2026 | 18.22 | 18.56 | 18.87 | 18.05 | 1.43M | -3.09% |
| Sep 30, 2026 | 18.80 | 18.28 | 18.94 | 17.94 | 1.73M | +3.10% |
| Sep 29, 2026 | 18.24 | 17.90 | 18.31 | 17.75 | 1.50M | +2.10% |
| Sep 28, 2026 | 17.86 | 18.16 | 18.16 | 17.60 | 1.55M | -1.87% |
| Sep 25, 2026 | 18.20 | 18.03 | 18.35 | 17.76 | 1.34M | +1.28% |
| Sep 24, 2026 | 17.97 | 17.52 | 18.11 | 17.18 | 2.07M | +1.87% |
| Sep 23, 2026 | 17.64 | 18.20 | 18.47 | 17.09 | 2.09M | -3.00% |
| Sep 22, 2026 | 18.18 | 18.23 | 18.56 | 17.97 | 1.67M | +0.64% |
| Sep 21, 2026 | 18.07 | 17.74 | 18.45 | 17.39 | 2.11M | +2.55% |
| Sep 18, 2026 | 17.62 | 17.65 | 17.95 | 17.37 | 5.18M | -0.34% |
| Sep 17, 2026 | 17.68 | 17.53 | 18.05 | 17.37 | 2.58M | +2.31% |
| Sep 16, 2026 | 17.28 | 18.08 | 18.11 | 17.25 | 2.33M | -4.48% |
Full history, intraday charts and downloads are in the GTA Terminal.
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the Menin-KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, both currently in pivotal trials.
People also watch
FAQ
What is the price of Syndax Pharmaceuticals, Inc. today?
Syndax Pharmaceuticals, Inc. (SNDX) last traded at 13.75, down 16.92% on the day.
What is the 52-week range of SNDX?
Over the past 52 weeks SNDX has traded between 12.99 and 25.59.
Is SNDX a buy or a sell?
Daily technical indicators currently read Strong Sell (0 buy vs 8 sell signals). That is a mechanical reading, not advice.
Get the GTA Daily Brief
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.